About RxDataLab

RxDataLab provides competitive intelligence on biotechnology companies by analyzing what they actually do, not what they say they’re doing.

This work combines systematic data infrastructure with domain expertise in neuroscience and life sciences data engineering. I’ve spent 5+ years building data pipelines for biotech and research institutions, and apply those same methods to surface operational signals that traditional analysis misses—clinical trial changes, hiring patterns, regulatory filings, patent activity, and other technical disclosures that companies release without press coverage.

Most biotech research focuses on what companies say. RxDataLab focuses on what they do.

Cutting Through the Hype

Investor and competitive intelligence research often weighs company presentations, analyst reports, and media coverage heavily. While these can be useful, they are highly curated and biased in favor of company messaging.

RxDataLab monitors operational activity and technical evidence from public sources, particularly those released without fanfare:

• Clinical trial design, endpoints, enrollment changes, and protocol amendments
• Patent filings, ownership structures, and expiration strategies
• Technical hiring across R&D, clinical, and regulatory teams
• Scientific publications and their consistency with public claims
• Regulatory activity, supply chain signals, and manufacturing moves

See our Education and Guides for more on these analytical methods.

What We Offer

Clinical Trial Intelligence Platform

The trial tracker is built for investors who need systematic pipeline monitoring:

• Company-centric pipeline views with canonical name mapping
• Automatic trial change detection with complete historical records
• Financial screening and market data integrated with trial status
• Project watchlists and research notes connected to live data
• Daily updates from ClinicalTrials.gov, SEC filings, and market feeds

This platform aggregates public data that’s otherwise scattered across registries, regulatory databases, and financial sources. Currently in limited early access.

Custom Intelligence Services

This is a specialized intelligence operation, not a generalist research provider. For questions that require domain expertise rather than automated monitoring, we provide targeted research and technical due diligence:

• Competitive assessments - Evaluations of therapeutic programs, competitive landscapes, and technical risks based on operational signals
• Technical program reviews - Independent evaluation of scientific claims, trial designs, and development strategies
• Signal analysis consulting - Helping investment teams apply OSINT techniques to biotech due diligence

RxDataLab offers custom intelligence reports, dashboards, targeted analysis, and data platform access for investment teams, strategy groups, and corporate development professionals.

Interested in learning more? Get early access to the trial tracker, read our biotech intelligence research, or see our analytical guides.